» Articles » PMID: 28504703

Polygenic Transmission Disequilibrium Confirms That Common and Rare Variation Act Additively to Create Risk for Autism Spectrum Disorders

Abstract

Autism spectrum disorder (ASD) risk is influenced by common polygenic and de novo variation. We aimed to clarify the influence of polygenic risk for ASD and to identify subgroups of ASD cases, including those with strongly acting de novo variants, in which polygenic risk is relevant. Using a novel approach called the polygenic transmission disequilibrium test and data from 6,454 families with a child with ASD, we show that polygenic risk for ASD, schizophrenia, and greater educational attainment is over-transmitted to children with ASD. These findings hold independent of proband IQ. We find that polygenic variation contributes additively to risk in ASD cases who carry a strongly acting de novo variant. Lastly, we show that elements of polygenic risk are independent and differ in their relationship with phenotype. These results confirm that the genetic influences on ASD are additive and suggest that they create risk through at least partially distinct etiologic pathways.

Citing Articles

Generation and Characterization of a Knockout Mouse of an Enhancer of .

Hurtado E, Wotton J, Gulka A, Burke C, Ng J, Bah I bioRxiv. 2025; .

PMID: 39829799 PMC: 11741297. DOI: 10.1101/2025.01.09.631762.


Prematurity and Genetic Liability for Autism Spectrum Disorder.

Zhang Y, Yahia A, Sandin S, Aden U, Tammimies K medRxiv. 2024; .

PMID: 39606368 PMC: 11601743. DOI: 10.1101/2024.11.20.24317613.


Common genetic variants contribute more to rare diseases than previously thought.

Breen G Nature. 2024; 636(8042):304-305.

PMID: 39567806 DOI: 10.1038/d41586-024-03554-4.


Examining the role of common variants in rare neurodevelopmental conditions.

Huang Q, Wigdor E, Malawsky D, Campbell P, Samocha K, Chundru V Nature. 2024; 636(8042):404-411.

PMID: 39567701 PMC: 11634775. DOI: 10.1038/s41586-024-08217-y.


Resolving complex duplication variants in autism spectrum disorder using long-read genome sequencing.

Eisfeldt J, Higginbotham E, Lenner F, Howe J, Fernandez B, Lindstrand A Genome Res. 2024; 34(11):1763-1773.

PMID: 39472019 PMC: 11610597. DOI: 10.1101/gr.279263.124.


References
1.
Hagenaars S, Harris S, Davies G, Hill W, Liewald D, Ritchie S . Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia. Mol Psychiatry. 2016; 21(11):1624-1632. PMC: 5078856. DOI: 10.1038/mp.2015.225. View

2.
Kosmicki J, Samocha K, Howrigan D, Sanders S, Slowikowski K, Lek M . Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat Genet. 2017; 49(4):504-510. PMC: 5496244. DOI: 10.1038/ng.3789. View

3.
Lee S, Ripke S, Neale B, Faraone S, Purcell S, Perlis R . Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013; 45(9):984-94. PMC: 3800159. DOI: 10.1038/ng.2711. View

4.
Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View

5.
. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View